Machine Learning and Radiomics for Characterizing Breast Masses

Phase 1, open-label, single-arm trial in breast carcinoma, sponsored by University of Southern California. Primary endpoints: Radiomics-based ML-classifier framework at 12 months and Performance of radiomics-based ML approach to prevent unnecessary biopsies at 12 months. Started Nov 2020; status: recruiting.